Merck to Offer Big Bonuses to Executives if It Is Taken Over
551275
Merck adopted the plan at a time that its stock is down sharply and its ability to thrive as an independent company is uncertain.
39475
NEW YORK - Merck &amp; Co. Inc. has adopted a severance benefits plan aimed at protecting key managers in the event the company is taken over - a growing possibility since the withdrawal of arthritis drug Vioxx sent shares tumbling.
307128
Drugmaker Merck acknowledged Monday that it has hired an executive search firm to look for a successor to Chairman and CEO Raymond Gilmartin, but said it did so before its decision
308818
A growing number of chief executives, like AT&amp;T's Ed Whitacre, are getting rich, lifetime compensation deals.
160458
Big-ticket executives and the  directors who bankroll them will be top targets for activist  shareholders as the proxy campaigns for next year's annual  corporate meetings get under way, governance experts predict.
480970
Swiss biotech company Addex Pharmaceuticals SA  said it could receive more than $700 million from Merck & Co Inc  for a licensing deal on its ADX63365 drug to treat schizophrenia, lifting its shares.
328042
NEW YORK, October 12  - The global pharmaceutical giant, Merck &amp; Company (MRK.NYS) plans to appoint a new CEO by the end of next year.
158632
When Raymond Gilmartin became chairman of the drug maker Merck, it was close to introducing several new medicines. Now, the company is in crisis.
663916
Merck & Co. Inc. MRK.N will increase  the number of jobs cut to 5,100 by year end, up from an  original target of 4,400 because its earnings have been hurt by  the withdrawal of its arthritis drug Vioxx.
646011
Drugmaker Merck &amp; Co., under financial siege since pulling its top painkiller Vioxx off the market in September, said Monday it has adopted a plan that
102650
Drugs giant Merck & Co. which pulled its blockbuster painkiller Vioxx from shelves in September, is about to become the target of hundreds of plaintiffs' lawyers, the New York Times reported on Friday.
152280
Merck & Co. Inc. has adopted a severance benefits plan aimed at protecting key managers in the event the company is taken over -- a growing possibility since the withdrawal of arthritis drug Vioxx sent shares tumbling.
623702
Beleaguered pharmaceutical giant Merck &amp; Co. Inc. has appointed a special committee of board members and a retired federal judge to review the company&#39;s actions before it
279929
With its stock down sharply and its ability to thrive as an independent company uncertain, Merck has adopted a special plan that will give its top executives big bonuses if the company is taken over.
81161
Drug giant Merck pulled its painkiller Vioxx because it increased the risk of heart attacks and strokes. Now the company may face thousands of lawsuits.
446961
This article was reported and written by Alex Berenson, Gardiner Harris, Barry Meier and Andrew Pollack. In May 2000, executives at Merck, the pharmaceutical giant under siege for its
506494
Several of the world's top  drugmakers may weigh acquiring Bristol-Myers Squibb Co.   after it fired its chief executive, although suitors seem  unlikely to bid before next summer, analysts said.